The recent dip in agilon Health, inc.’s (NYSE:AGL) stock price by 10% has left insiders disappointed, considering they invested US$747.9k at an average price of US$11.17 per share over the past year. The value of their investment has now fallen to US$356.4k due to recent losses. While insider transactions shouldn’t be the sole basis for investment decisions, keeping an eye on them is wise.
Over the last 12 months, agilon health insiders have been buying shares, with President Steven Sell making the largest single purchase of US$498k at US$11.14 per share. This indicates confidence in the company’s future, despite the current share price being US$5.32. Insider ownership in agilon health stands at 1.3%, worth around US$28m, showing some alignment between management and shareholders.
While no insider has traded agilon health shares in the last quarter, transactions over the past year are positive. Understanding the risks involved is crucial when considering investment opportunities. In this case, there are 2 warning signs with agilon health that should be taken into account.
This article by Simply Wall St provides commentary based on historical data and analyst forecasts, serving as informative content rather than financial advice. For more interesting investment opportunities, check out our free list of growing companies with recent insider purchasing.
For any feedback or concerns about this article, you can reach out to us directly or email our editorial team at editorial-team@simplywallst.com.
Read More Health News
